Stryker Corp. (NYSE:SYK) saw unusually-strong trading volume on Friday . Approximately 1,397,792 shares changed hands during mid-day trading, a decline of 8% from the previous session’s volume of 1,518,678 shares.The stock last traded at $121.62 and had previously closed at $122.30.

SYK has been the topic of several research reports. Jefferies Group raised their price objective on shares of Stryker Corp. from $74.00 to $83.00 and gave the stock a “hold” rating in a research report on Monday, March 28th. Guggenheim initiated coverage on shares of Stryker Corp. in a research report on Wednesday, June 8th. They set a “buy” rating and a $134.00 price objective on the stock. Goldman Sachs Group Inc. raised their price objective on shares of Stryker Corp. from $107.00 to $119.00 in a research report on Friday, April 8th. Zacks Investment Research raised shares of Stryker Corp. from a “hold” rating to a “buy” rating and set a $130.00 price objective on the stock in a research report on Tuesday, June 21st. Finally, Leerink Swann raised their price objective on shares of Stryker Corp. from $87.00 to $92.00 and gave the stock an “outperform” rating in a research report on Monday, March 28th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $109.23.

The company has a market capitalization of $45.66 billion and a PE ratio of 28.57. The stock’s 50 day moving average price is $116.64 and its 200-day moving average price is $106.09.

Stryker Corp. (NYSE:SYK) last announced its earnings results on Wednesday, April 20th. The medical technology company reported $1.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.04. During the same quarter in the prior year, the company earned $1.11 EPS. The company earned $2.50 billion during the quarter, compared to the consensus estimate of $2.47 billion. The business’s quarterly revenue was up 4.9% on a year-over-year basis. Analysts anticipate that Stryker Corp. will post $5.76 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Thursday, June 30th will be given a $0.38 dividend. The ex-dividend date of this dividend is Tuesday, June 28th. This represents a $1.52 dividend on an annualized basis and a yield of 1.25%.

In other Stryker Corp. news, Director Ronda E. Stryker sold 6,000 shares of the company’s stock in a transaction dated Tuesday, July 12th. The shares were sold at an average price of $122.75, for a total value of $736,500.00. Following the completion of the sale, the director now directly owns 193,142 shares of the company’s stock, valued at approximately $23,708,180.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronda E. Stryker sold 12,000 shares of the company’s stock in a transaction dated Monday, April 25th. The shares were sold at an average price of $108.69, for a total transaction of $1,304,280.00. Following the completion of the sale, the director now directly owns 193,142 shares of the company’s stock, valued at $20,992,603.98. The disclosure for this sale can be found here.

Other large investors have modified their holdings of the company. Bragg Financial Advisors Inc increased its stake in shares of Stryker Corp. by 0.3% in the fourth quarter. Bragg Financial Advisors Inc now owns 10,900 shares of the medical technology company’s stock worth $1,013,000 after buying an additional 35 shares during the last quarter. Essex Financial Services Inc. raised its stake in Stryker Corp. by 0.3% in the fourth quarter. Essex Financial Services Inc. now owns 11,338 shares of the medical technology company’s stock worth $1,054,000 after buying an additional 30 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in Stryker Corp. by 3.8% in the fourth quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 11,356 shares of the medical technology company’s stock worth $1,055,000 after buying an additional 420 shares in the last quarter. Brown Advisory Securities LLC raised its stake in Stryker Corp. by 0.8% in the fourth quarter. Brown Advisory Securities LLC now owns 12,761 shares of the medical technology company’s stock worth $1,186,000 after buying an additional 107 shares in the last quarter. Finally, Victory Capital Management Inc. raised its stake in Stryker Corp. by 50.0% in the fourth quarter. Victory Capital Management Inc. now owns 13,405 shares of the medical technology company’s stock worth $1,246,000 after buying an additional 4,467 shares in the last quarter.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.